FilingReader Intelligence
Hester Biosciences reports 17% standalone profit growth in FY25
July 11, 2025 at 08:19 AM UTC•By FilingReader AI
Hester Biosciences reported standalone net profit growth of 17% to INR 318.42 million for FY25, while consolidated profit surged 36% to INR 288.26 million.
Standalone revenue reached INR 2,864.66 million with consolidated revenue of INR 3,111.02 million. The board recommended a dividend of INR 7 per share.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
BSE:HESTERBIO•Bombay Stock Exchange
News Alerts
Get instant email alerts when Hester Biosciences publishes news
Free account required • Unsubscribe anytime